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METHODS: A cross sectional, multi-site study of boys aged 6-17 years with 
haemophilia was undertaken in children and their parents in the UK. Age 
appropriate questionnaires were completed including socio-demographic data, 
questions about haemophilia and sports activities, HRQoL (KINDL, Haemo-QoL) 
and subjective physical performance (HEP-TEST-Q). Clinical data including 
orthopaedic status were collected. RESULTS: Eighty four haemophilia boys, mean 
age of 11.52 years (SD=3.4), were enrolled. 92.3% had haemophilia A, 51.9% were 
severely affected; 66.3% received prophylaxis and had a good orthopaedic status 
(M=1.55±3.6). 90.5% participated in regular sporting activity. HRQoL in children 
was generally good, with highest impairments in boys aged 8-12 years. Boys aged 
8-17 years reported good physical performance (M=80.0, SD=16.0) with highest 
impairments in the dimensions ‘endurance’ and ‘mobility’. Children with a more 
sedentary lifestyle had more haemophilia-related days lost than those with a 
less sedentary life style (p<.032). Older boys not doing sport showed more 
impairments in the HRQoL dimensions ‘feeling’ (p<.014) and ‘family’ (p<.013). 
Children doing sport reported better physical performance in all domains of the 
HEP-Test-Q (p<.0001). CONCLUSIONS: Boys doing sport had significantly better 
physical performance and HRQoL than boys not doing sport. Sedentary life style 
had a negative impact on the subjective physical performance and number of 
days lost of children. Doing sport did not increase the risk of bleeding or 
developing target joints. Encouraging haemophilia boys to participate in sport 
will have a direct impact on their overall HRQoL.  
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OBJECTIVES: ICECAP-O is an instrument for measuring capability (a person’s 
ability to function), providing an alternative to preference-based health status to 
value an intervention's benefit. This study aimed to test construct validity of 
ICECAP-O and identify its relationship with measures of health status, physical 
and cognitive functioning, and psychological well-being. METHODS: The Medical 
Crises in Older People (MCOP) programme recruited three samples of older (≥65 
years) people: (a) discharged from an acute medical unit; (b) with physical and 
mental health problems admitted to hospital; (c) residing in care homes. MCOP 
collected socio-demographic and outcome data using: EQ-5D (health status); 
Barthel ADL Index (physical functioning); MMSE (cognitive functioning); GHQ-12 
(psychological well-being; in samples (a) and (c)), and self-reported or proxy 
UDemQoL (dementia quality of life; sample (b)). Direct comparison of the 
ICECAP-O with four outcomes identified construct validity using: (i) correlation 
between tariff scores (Pearson correlation coefficient (PCC)); (ii) tests of 
association between domain scores (χ2; one-way ANOVA). RESULTS: A total of 
601 older patients completed both ICECAP-O and at least one other outcome 
measure (a=377; b=85; c=139). Pearson correlation coefficients between capability 
and health status were significant (p<0.05) but differed by study sample: 0.57 (a); 
0.38 (b); 0.18 (c). Capability had a stronger significant correlation with 
psychological well-being and self-reported (not proxy) dementia quality of life 
(PCC = 0.70 (a); 0.36 (c); 0.54 (b)) than any other outcome. Correlation between 
capability and cognitive/physical functioning was significant in sample (a) and 
(c), but not (b) (PCC = 0.26/0.57 (a); 0.18/0.20 (c); 0.04/0.07 (b)). Association and 
correlation with the ICECAP-O varied by: domain; tariff scores; and sample. 
CONCLUSIONS: This study provides evidence to support the construct validity of 
ICECAP-O. Capability has a complex relationship with the other outcomes, which 
needs consideration when evaluating the benefits of interventions for older 
people.  
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BACKGROUND: Up to 30% of haemophilia patients develop inhibitors, which 
complicate not only the bleeding treatment, but also impact on patients’ health-
related quality of life (HRQoL). Inhibitor patients have to face additional 
problems, thus inhibitor-specific instruments are needed to assess their HRQoL 
adequately. OBJECTIVES: Development of a disease-specific instrument 
evaluating the impact of different treatment regimens on inhibitor patients of 
different age-groups. METHODS: The development of an inhibitor-specific 
questionnaire was based on a parallel approach in three countries consisting of 
different phases: 1) preparation phase including evaluation of existing 
haemophilia-specific questionnaires and expert interviews with clinicians to 
identify relevant aspects and domains; 2) developmental phase including focus 
groups (adults, adolescents, parents of inhibitor children) to identify problems 
and specific needs, and construct of questionnaires; 3) pilot-testing of 
questionnaires and their revision; 4) field-testing phase including psychometric 
testing and validation of questionnaires in four countries. RESULTS: 
Haemophilia treaters and nurses agreed as ‘very important’ upon 13 items based 
on existing haemophilia-specific questionnaires for adult patients (Haem-A-QoL, 
Hemofilia-QoL, Haemo-QoL-A, HAL) and on seven items for paediatric patients 
(Haemo-QoL, CHO-KLAT, Hemo-Sat, HEP-TEST-Q). Seven focus groups were 
conducted separately for adults, adolescents and parents of inhibitor children in 
Italy (n=11), UK (n=7) and Germany (n=6). Based upon clinician consensus and 
statements of focus groups three age-group questionnaires were constructed and 
pilot-tested in 47 inhibitor patients and their caregivers. Cognitive debriefing 
results and psychometric testing led to item omission or rewording of the 
questionnaires. The revised versions were then field tested and validated in 44 
inhibitor patients and caregivers (18 adults, two adolescents, 24 parents) and 
revealed excellent psychometric characteristics. CONCLUSIONS: The INHIB-QoL 
proved to be a reliable and valid instrument for the assessment of HRQoL in 
inhibitor patients and is now available for the evaluation of treatment effects on 
the HRQoL of inhibitor patients.  
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OBJECTIVES: Challenges to controlling diabetes may impact diabetes patients’ 
quality of life (QOL). Individuals vary in self-care behaviors. The objective of this 
study is to identify relationship between self-care behavior, assessment of 
chronic care, distress, and diabetes-related QOL in patients stratified by their 
glycosylated hemoglobin level (HbA1c). METHODS: Patients seeking care at the 
local VHA during 2009-2010 with a recorded HbA1c level were randomly selected 
from administrative data, and surveys mailed. 126(38%) respondents returned 
surveys. Self administered survey included Diabetes-39 (Diabetes-related QOL), 
Summery of Diabetes Self-Care Activities (Diabetes self-care), Patient assessment 
of Chronic Illness Care (PACIC), and Diabetes Distress Scale. HbA1c was 
dichotomized into <=7 vs. >7. Regression models assessed predictors of diabetes-
related QOL. RESULTS: Participants were predominantly white (63%), married 
(60%), and functionally independent (83%). Unadjusted models indicated that 
individuals reporting high diabetes-related distress or social constraints are 
more likely to experience poor QOL (p<0.0001), while patients with higher 
adherence to medication experienced high diabetes-related QOL, but only in 
patients with HbA1c levels <=7 (p<0.05). Surprisingly, patients with higher self-
care on blood-glucose testing, and having higher goal-setting behavior 
experienced poor diabetes-related QOL (p<0.01). This may be attributed to the 
daily burdens of achieving goals in patients with HbA1c levels >7. After adjusting 
for patient characteristics (e.g., age, gender, education, and race), higher 
diabetes-related distress was significant predictor of lower diabetes related QOL 
irrespective of HbA1c level. But PACIC summary score, especially higher goal-
setting, and problem-solving were significant predictors of lower diabetes-
related QOL only in patients with HbA1c level over 7. CONCLUSIONS: Diabetes 
related distress affects QOL in diabetes patients. Providers can help reduce 
distress by providing behavioral and emotional support as well as diabetes 
education; in addition setting achievable goals especially in patients with HbA1c 
levels higher than 7, may help improve patients’ diabetes-related QOL.  
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OBJECTIVES: To determinate the impact of a managed care program for multiple 
sclerosis (MS) patients in Colombia through changes in health-related quality of 
life (HRQoL). METHODS: Seeking to improve the quality of life of MS patients 
treated with interferon beta 1b it was established a two-mode (basic or full) 
patients support program at each stage of illness. To estimate the program 
impact it was used the econometric differences method comparing the HRQoL 
measures from a treatment group defined as the patients in the full mode 
program with those from a control group defined as the patients in the basic 
mode program. The dependent variable was SF6D measures, and the 
independent variables were each mode of the support program, sex and three 
levels of disability (mild, moderate and severe) were control variables. The SF6D 
utility measures were obtained by converting SF36 results from 360 patients (a 
sample calculated to be statistically significant at country level), evaluated since 
January 2010 to April 2010 using the Quality Metric Health Outcomes® software 
4.0. RESULTS: The HRQoL of patients was 0.669 (0.301-1). At average a male 
(0.689) patient has better HRQoL measure than the woman (0.660) patient. The 
linear regression showed that patients in the full mode would have HRQoL 
measures of 0.781, 0.723 and 0.648 for mild, moderate and severe disability 
respectively, compared with 0.742, 0.644 and 0.657 in the basic mode 
respectively. The differences in HRQoL between full and basic modes were 0.039 
(P<0.05) in the mild disability, 0.079 (P<0.05) in the moderate disability and there 
were not found significant difference in patients with severe disability 
CONCLUSIONS: The support program does impact positively on the HRQoL in MS 
patients with a mild or moderate disability for the Colombian context. These 
results suggest that best outcomes come from early entry at this support 
program.  
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